MEASUREMENT OF SPECTRAL SHIFT AND LIFETIME CHANGES OF NOVEL DYES

新型染料的光谱偏移和寿命变化的测量

基本信息

  • 批准号:
    7724272
  • 负责人:
  • 金额:
    $ 1.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The rapid development of optical imaging systems for diagnostic and therapeutic use has been greatly enhanced by the development of highly fluorescent probes. In particular, imaging probes such as exogenous fluorophores that are tagged to proteins or nanoparticles (e.g. polymers and other metals) have demonstrated cancer-specific imaging in small animals. Agents are typically developed to have specificity to a cancer-specific enzyme, receptor, or metabolic by-product, and thus enable functional and molecular imaging within the whole body. Optical imaging agents that emit in the near-infrared (NIR) are favorable for deep tissue imaging where background autofluorescence is low. To aid in the design of these agents, in vitro diagnostics are necessary in order to characterize lifetime and spectral changes upon binding prior to small animal injection and clinical translation. Flow cytometry is an ideal method for these characterization studies since it allows measurement of free dye, dye bound in solution to other molecules and dye bound to cells and beads. The capabilities in lifetime measurement and full spectral flow cytometry are of particular interest in characterizing the new polymer dyes due to the complex molecular interactions that can occur upon binding of the dye with the polymer as well as binding of the polymer with cellular receptors. Upon development of the full-spectral phase-sensitive flow cytometer, cells tagged with exogenous fluorophores, polymer-bound fluorophores, or nanoparticle-enhanced fluorophores, will be provided by Dr. Chun Li's group for the measurement of lifetime and discrimination of intrinsic fluorescence signatures from cells. A number of approaches to analyze fluorophore-protein and polymer constructs for diagnostic imaging will be planned. First, the possibility of multi-exponential decay is present when a fluorophore is bound to different sites on a polymer. Therefore multi-frequency measurements on a high-throughput phase system will be used to resolve heterogeneous fluorescence decay and fit the phase data to multi-exponential decay models to more accurately obtain the fluorophore concentration. Secondly, lifetime changes may result depending on proximity of the fluorophore to different polymer residues. Fluorophores that are more intercalated at one location on the polymer may not be available to quenching molecules as are fluorophores that are bound to alternate monomers. Thus, lifetime measurements will be acquired to identify the binding sites of the fluorophore to the polymer. Thirdly, lifetime changes in exogenous dyes bound to cell surfaces may occur due to self-quenching because the number of fluorophores bound to the cell varies, and the number of binding sites on the cell surface will vary. Lifetime measurements will be performed to accurately measure the quenching effects and optimize cell-surface binding. Lastly, the lifetime of a dye upon internalization into a cancer cell will be measured. Here, lifetime measurements will be useful when combined with sorting in order to separate cells that have internalized dye-ligand constructs or cells with dyes bound to receptors over-expressed on the surface of the cell.
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 由于高荧光探针的发展,用于诊断和治疗的光学成像系统的快速发展得到了极大的促进。特别是,标记在蛋白质或纳米颗粒(例如聚合物和其他金属)上的外源荧光团等成像探针已经在小动物中展示了癌症特异性成像。药物通常被开发成对癌症特异性酶、受体或代谢副产物具有特异性,从而在整个身体内进行功能和分子成像。在近红外(NIR)中发射的光学成像剂对于背景自发荧光低的深层组织成像是有利的。为了帮助这些试剂的设计,体外诊断是必要的,以便在小动物注射和临床翻译之前表征结合后的寿命和光谱变化。流式细胞术是这些表征研究的理想方法,因为它可以测量游离染料、溶液中与其他分子结合的染料以及与细胞和珠子结合的染料。由于染料与聚合物结合以及聚合物与细胞受体结合时可能发生复杂的分子相互作用,因此寿命测量和全光谱流式细胞术在表征新的聚合物染料方面特别有兴趣。 在开发全光谱相敏流式细胞仪后,李春博士的团队将提供标记有外源荧光团、聚合物结合荧光团或纳米颗粒增强荧光团的细胞,用于测量细胞的寿命和辨别细胞的内在荧光信号。将规划一些分析荧光团-蛋白质和聚合物结构以用于诊断成像的方法。首先,当一个荧光团结合到聚合物上的不同位置时,存在多指数衰减的可能性。因此,高通量相系统上的多频测量将被用来解决非均相荧光衰减,并将相数据拟合为多指数衰减模型,以更准确地获得荧光团浓度。其次,寿命的变化可能取决于荧光团与不同聚合物残基的接近程度。在聚合物的一个位置插入更多的荧光团可能不能用于猝灭分子,与交替单体结合的荧光团也是如此。因此,将获得寿命测量以确定荧光团与聚合物的结合位置。第三,结合到细胞表面的外源染料的寿命可能由于自猝灭而发生变化,因为结合到细胞上的荧光团的数量不同,细胞表面的结合位点的数量也会不同。将进行寿命测量,以准确测量猝灭效应并优化细胞表面结合。最后,我们将测量染料内化进入癌细胞后的寿命。在这里,寿命测量与分类相结合将是有用的,以便分离具有内化的染料配体结构的细胞或具有与细胞表面过度表达的受体结合的染料的细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHUN LI其他文献

CHUN LI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHUN LI', 18)}}的其他基金

Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
开发基于不可逆电穿孔的合理组合以增强癌症免疫疗法对胰腺导管腺癌的活性
  • 批准号:
    10363932
  • 财政年份:
    2022
  • 资助金额:
    $ 1.61万
  • 项目类别:
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
开发基于不可逆电穿孔的合理组合以增强癌症免疫疗法对胰腺导管腺癌的活性
  • 批准号:
    10559607
  • 财政年份:
    2022
  • 资助金额:
    $ 1.61万
  • 项目类别:
GS-441524 is Pharmacodynamically Equivalent to Remdesivir and Pharmacokinetically Superior Drug for the Treatment of COVID-19
GS-441524在药效学上与瑞德西韦相当,是治疗COVID-19的药代动力学优越的药物
  • 批准号:
    10199288
  • 财政年份:
    2021
  • 资助金额:
    $ 1.61万
  • 项目类别:
Multifunctional Hollow Gold Nanospheres for Concurrent Photothermal-Chemotherapy
用于同步光热化疗的多功能空心金纳米球
  • 批准号:
    9039018
  • 财政年份:
    2015
  • 资助金额:
    $ 1.61万
  • 项目类别:
MEASUREMENT OF SPECTRAL SHIFT AND LIFETIME CHANGES OF NOVEL DYES
新型染料的光谱偏移和寿命变化的测量
  • 批准号:
    8361774
  • 财政年份:
    2011
  • 资助金额:
    $ 1.61万
  • 项目类别:
MEASUREMENT OF SPECTRAL SHIFT AND LIFETIME CHANGES OF NOVEL DYES
新型染料的光谱偏移和寿命变化的测量
  • 批准号:
    8169410
  • 财政年份:
    2010
  • 资助金额:
    $ 1.61万
  • 项目类别:
Near-Infrared Fluorescence Nanoparticles for Targeted O*
用于靶向 O* 的近红外荧光纳米颗粒
  • 批准号:
    7919135
  • 财政年份:
    2009
  • 资助金额:
    $ 1.61万
  • 项目类别:
MEASUREMENT OF SPECTRAL SHIFT AND LIFETIME CHANGES OF NOVEL DYES
新型染料的光谱偏移和寿命变化的测量
  • 批准号:
    7956793
  • 财政年份:
    2009
  • 资助金额:
    $ 1.61万
  • 项目类别:
Near-Infrared Fluorescence Nanoparticles for Targeted Optical Imaging
用于靶向光学成像的近红外荧光纳米颗粒
  • 批准号:
    7478768
  • 财政年份:
    2005
  • 资助金额:
    $ 1.61万
  • 项目类别:
Near-Infrared Fluorescence Nanoparticles for Targeted O*
用于靶向 O* 的近红外荧光纳米颗粒
  • 批准号:
    7127285
  • 财政年份:
    2005
  • 资助金额:
    $ 1.61万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
  • 批准号:
    24K15172
  • 财政年份:
    2024
  • 资助金额:
    $ 1.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
  • 批准号:
    23K04928
  • 财政年份:
    2023
  • 资助金额:
    $ 1.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
  • 批准号:
    10744934
  • 财政年份:
    2023
  • 资助金额:
    $ 1.61万
  • 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
  • 批准号:
    573688-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 1.61万
  • 项目类别:
    University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10704557
  • 财政年份:
    2022
  • 资助金额:
    $ 1.61万
  • 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10537846
  • 财政年份:
    2022
  • 资助金额:
    $ 1.61万
  • 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
  • 批准号:
    2753921
  • 财政年份:
    2022
  • 资助金额:
    $ 1.61万
  • 项目类别:
    Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
  • 批准号:
    10328140
  • 财政年份:
    2022
  • 资助金额:
    $ 1.61万
  • 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
  • 批准号:
    10621368
  • 财政年份:
    2021
  • 资助金额:
    $ 1.61万
  • 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
  • 批准号:
    2111821
  • 财政年份:
    2021
  • 资助金额:
    $ 1.61万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了